Identifying Cardiomyopathy Genes in Mice and Drosophila

描述（由申请人提供）：遗传方法，优先用于既能准确测量心功能又能有效进行遗传筛选的模型系统，对于确定心力衰竭的遗传基础取得实质性进展是必要的。在建议中，我们将测试一个假设，即强大的诱变剂n -乙基- n -亚硝基脲（ENU），小鼠诱变和果蝇基因删除筛选将导致发现新的人类心力衰竭致病和修饰基因。为了验证这些假设，我们在8周龄和16周龄的成年小鼠中使用无创超声心动图进行了隐性突变筛选，以筛查心功能异常，并已经确定了1号染色体上映射到心肌病表型的遗传区域。为了补充小鼠研究，我们建议使用苍蝇来鉴定新的心肌病基因。果蝇遗传学提供了超过19,000个分子定义的p -元件，这些p -元件插入整个果蝇基因组，促进了高密度基因组覆盖的产生。我们开发了一种创新的方法来检测成年清醒果蝇的心功能表型，并在短原肠胚形成（sog）基因中发现了导致扩张性心肌病的p元素突变。基于我们的初步研究结果，我们提出小鼠和果蝇遗传学可以识别负责人类扩张型心肌病的新基因和机制。因此，我们提出以下具体目标：目的1：在成年小鼠中使用ENU表型驱动的隐性筛选来鉴定引起心肌病的新基因。我们建议在心功能异常的ENU家族中定位1号染色体上的致病基因。目的2：探讨dpp/BMP信号通路突变导致成年果蝇扩张型心肌病的生化和遗传机制。基因互补实验将在果蝇中进行，以证明sog缺乏导致心肌病。目的3：测试小鼠压力过载条件下BMP通路拮抗作用降低是否会导致心肌病表型。TAG实验将在敲除缺乏内源性哺乳动物BMP拮抗剂chordin和noggin的小鼠中进行。目的4：通过对果蝇的缺失突变进行全基因组筛选，鉴定引起心肌病的新基因。Exelixis收集的PiggyBac衍生缺失突变体的果蝇杂合将使用光学相干断层扫描进行心肌病筛查，然后对致病基因进行精细定位。因此，这四个综合目标将利用小鼠和果蝇遗传学的力量来识别和评估新的候选基因在心肌病中的作用。

DESCRIPTION (provided by applicant): Genetic approaches, preferentially in model systems that both allow accurate measurement of heart function as well as efficient genetic screening, are necessary for substantial progress in identifying the genetic basis of heart failure. In proposal, we will test the hypothesis that the powerful mutagen, N-ethyl-N- nitrosourea (ENU), mutagenesis in mice, and gene-deletion screens in Drosophila, will lead to the discovery of novel disease-causing and disease-modifying genes for human heart failure. In order to test these hypotheses, we have performed a recessive mutagenesis screen in adult mice at 8 and 16 weeks of age using non-invasive echocardiography to screen for abnormalities in cardiac function and have already identified a heritable region on chromosome 1 that maps to a cardiomyopathic phenotype. To complement the mouse studies we propose to use the fly to identify novel cardiomyopathic genes. Drosophila genetics provides more than 19,000 molecularly-defined P-elements inserted throughout the Drosophila genome that facilitate the generation of high-density genomic coverage. We have developed an innovative approach to phenotype cardiac function in adult awake Drosophila and have identified a P-element mutation in the short gastrulation (sog) gene that results in dilated cardiomyopathy. Based on our preliminary findings, we propose that mouse and Drosophila genetics can identify novel genes and mechanisms that are responsible for human dilated cardiomyopathies. Accordingly, we propose the following specific aims: Aim 1: To identify novel genes causing cardiomyopathy using an ENU phenotype-driven recessive screen in adult mice. We propose to map the disease causing gene located on chromosome 1 in the ENU family with abnormal cardiac function. Aim 2: To investigate the biochemical and genetic mechanisms through which mutations in the dpp/BMP signaling pathway lead to dilated cardiomyopathy in adult Drosophila. Genetic complementation experiments will be performed in Drosophila to prove that sog deficiency causes cardiomyopathy. Aim 3: To test whether decreased antagonism of the BMP pathway in mice, will result in a cardiomyopathic phenotype under conditions of pressure overload. TAG experiments will be performed in knock out mice deficient in the endogenous mammalian BMP antagonists chordin and noggin. Aim 4: To identify novel genes causing cardiomyopathy by performing a genome-wide screen of deletion mutants in Drosophila. Flies heterozygous for PiggyBac derived deletion mutants from the Exelixis collection will be screened for cardiomyopathy using optical coherence tomography followed by fine mapping of the disease-causing gene(s). Thus, these four integrated aims will harness the power of mouse and Drosophila genetics to identify and evaluate novel candidate genes for their role in cardiomyopathy.